Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 4 | 2020 | 223 | 1.670 |
Why?
|
| Placenta | 4 | 2020 | 493 | 1.470 |
Why?
|
| CD55 Antigens | 4 | 2014 | 9 | 1.410 |
Why?
|
| Complement Activation | 3 | 2020 | 52 | 1.010 |
Why?
|
| Complement C5a | 2 | 2015 | 23 | 0.980 |
Why?
|
| Complement C3 | 2 | 2020 | 47 | 0.790 |
Why?
|
| Receptors, Complement 3b | 1 | 2020 | 8 | 0.720 |
Why?
|
| Complement System Proteins | 1 | 2020 | 58 | 0.690 |
Why?
|
| Nitric Oxide | 2 | 2013 | 432 | 0.670 |
Why?
|
| Fetal Development | 1 | 2020 | 111 | 0.640 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2018 | 7 | 0.630 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 43 | 0.610 |
Why?
|
| Trophoblasts | 1 | 2018 | 112 | 0.570 |
Why?
|
| Complement C4a | 1 | 2015 | 4 | 0.520 |
Why?
|
| Complement Factor B | 1 | 2015 | 11 | 0.510 |
Why?
|
| Gene Expression | 1 | 2020 | 1565 | 0.490 |
Why?
|
| Complement Inactivator Proteins | 1 | 2014 | 3 | 0.480 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 151 | 0.460 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2014 | 26 | 0.440 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 86 | 0.440 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 108 | 0.440 |
Why?
|
| ELAV Proteins | 1 | 2013 | 13 | 0.420 |
Why?
|
| Caveolae | 1 | 2012 | 6 | 0.420 |
Why?
|
| Sp1 Transcription Factor | 1 | 2013 | 43 | 0.420 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2584 | 0.370 |
Why?
|
| Endometrium | 1 | 2012 | 276 | 0.340 |
Why?
|
| Epithelial Cells | 1 | 2014 | 900 | 0.330 |
Why?
|
| Pregnancy | 6 | 2020 | 7143 | 0.320 |
Why?
|
| Membrane Cofactor Protein | 2 | 2020 | 10 | 0.290 |
Why?
|
| Signal Transduction | 1 | 2014 | 4493 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2014 | 696 | 0.180 |
Why?
|
| Complement Inactivating Agents | 1 | 2020 | 11 | 0.180 |
Why?
|
| Cell Line | 3 | 2019 | 2772 | 0.180 |
Why?
|
| Receptors, Complement | 1 | 2020 | 31 | 0.180 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 15 | 0.170 |
Why?
|
| Female | 8 | 2020 | 65443 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 664 | 0.150 |
Why?
|
| Gene Frequency | 1 | 2020 | 713 | 0.150 |
Why?
|
| Adrenomedullin | 1 | 2019 | 74 | 0.150 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 145 | 0.140 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 109 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2813 | 0.140 |
Why?
|
| Up-Regulation | 1 | 2018 | 864 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 996 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2020 | 1318 | 0.120 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2014 | 19 | 0.120 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2014 | 18 | 0.110 |
Why?
|
| Insulin | 1 | 2019 | 1197 | 0.110 |
Why?
|
| Nitroso Compounds | 1 | 2013 | 8 | 0.110 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 23 | 0.110 |
Why?
|
| Fimbriae Proteins | 1 | 2013 | 20 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 350 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2012 | 46 | 0.100 |
Why?
|
| Humans | 8 | 2020 | 123122 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3046 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 198 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 162 | 0.100 |
Why?
|
| Cyclic GMP | 1 | 2012 | 92 | 0.100 |
Why?
|
| Endosomes | 1 | 2012 | 67 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 165 | 0.100 |
Why?
|
| Cysteine | 1 | 2013 | 133 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2528 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4342 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 490 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 571 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2013 | 1101 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 1291 | 0.080 |
Why?
|
| Adult | 3 | 2020 | 29030 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 1336 | 0.080 |
Why?
|
| Protein Binding | 1 | 2013 | 1741 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3249 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2013 | 978 | 0.070 |
Why?
|
| Young Adult | 1 | 2020 | 8864 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3267 | 0.060 |
Why?
|
| Mice | 1 | 2020 | 17483 | 0.050 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2019 | 16 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 33708 | 0.040 |
Why?
|
| Mutation | 1 | 2013 | 5771 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 204 | 0.040 |
Why?
|
| Middle Aged | 1 | 2015 | 25971 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 543 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 809 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 1113 | 0.030 |
Why?
|